[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Monoclonal Antibody Therapeutics Market Research and Outlook, 2020- Trends, Growth Opportunities and Forecasts to 2028

February 2021 | 110 pages | ID: M1470970856CEN
VPAResearch

US$ 4,880.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Monoclonal Antibody Therapeutics Market Report Overview
Monoclonal Antibody Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Monoclonal Antibody Therapeutics market types and applications. It is a focused study on Monoclonal Antibody Therapeutics market space including global and regional eight-year forecasts for revenues as well as proffers detailed snapshots of country-wide Monoclonal Antibody Therapeutics market revenues.

Economic Impact Analysis of COVID-19 on Monoclonal Antibody Therapeutics market growth opportunities
Monoclonal Antibody Therapeutics market is a dynamic industry with significant opportunities for business development but the current COVID-19 conditions caused uncertainty in forecasts, shifts in short term planning goals, focus on concerns related to near term cost management, and long term complexity management. During 2020, profit pool growth varied widely across the Monoclonal Antibody Therapeutics market as companies quickly aligning their strategies to the current market conditions succeeded largely. The report assists in identifying growth and business expansion opportunities that lie beneath the uncertainty.

What issues will matter in the Monoclonal Antibody Therapeutics industry in 2021 and beyond
The Monoclonal Antibody Therapeutics market report presents key trends and dynamics making an impact on the Monoclonal Antibody Therapeutics companies across the Americas, Europe, Asia Pacific, and Other markets and provides innovative approaches to stay ahead of the competition in the opportunity-rich Monoclonal Antibody Therapeutics market.

Strategies of Monoclonal Antibody Therapeutics market leaders
Monoclonal Antibody Therapeutics companies tend to opt for an integrated framework to boost Monoclonal Antibody Therapeutics market size, acquiring new capabilities, care management, consumer engagement, utilization optimization, expanding into new markets while reducing total costs across evolving healthcare ecosystems. This report presents the major short term and long term strategies being opted by Monoclonal Antibody Therapeutics companies to boost their market shares in the Monoclonal Antibody Therapeutics industry.

Segmentation Analysis of Global Monoclonal Antibody Therapeutics market outlook
The report forecasts global and regional Monoclonal Antibody Therapeutics market size at granular levels for diverse types, applications, end-use segments, technologies, and niche market opportunities. The global and regional Monoclonal Antibody Therapeutics market segmentation analysis and outlook enable you to build powerful marketing strategies and invest in the right growth segments based on a comprehensive understanding of dynamics.

Competitive Analysis of Monoclonal Antibody Therapeutics Global market size and forecasts for strategy and portfolio optimization
Leading companies are focusing on tactical and strategic product portfolio management. Key Monoclonal Antibody Therapeutics companies are analyzed in the market research study. The report presents a critical competitive understanding of the company’s fundamentals, financial situation, strategy, SWOT profiles, and others to make peer group comparisons.

Reasons to buy
Useful for entities across the Monoclonal Antibody Therapeutics industry value chain
This report is a useful tool for entities operating across the Monoclonal Antibody Therapeutics market including biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers, and other healthcare stakeholders. It assists in planning to enable develop new approaches to clinical development and commercialization.

Sound research methodology and Information sources

The Monoclonal Antibody Therapeutics market study is developed with deep knowledge and expertise across the healthcare system supported by historical datasets and advanced analytics.
  • Proven research methodologies
  • Proprietary market data, forecasts, and analyses
  • Global, Regional, and Country level details
  • Validated through both top-down and bottom-up approaches

Delivered in the form you need
  • Analyst insights
  • Qualitative analysis supported by quantitative data
  • User-friendly reports with easy to re-use charts and tables
  • Data provided in excel format as well
  • Direct analyst access provided
  • Print authentication provided for the single-user license as well
Comprehensive Coverage (Report Scope)-
Chapter 1 details the executive summary including key facts for 2021 and global healthcare and life sciences industry outlook to 2030
Chapter 2 is a report guide detailing market segments considered, countries analyzed and companies presented in the report
Chapter 3 presents the macro-economic and demographic market outlook for leading countries
Chapter 4 presents industry panorama for 2021, market trends, drivers, challenges, and end-user applications
Chapter 5 details dominant market types, applications, and regional outlook
Chapter 6 presents COVID Economic impact analysis with forecasts across multiple scenarios
Chapter 7 presents end-user market trends and outlook
Chapter 8 details North America Monoclonal Antibody Therapeutics market analysis including trends, country-level outlook
(Countries analyzed include the US, Canada, Mexico)
Chapter 9 details Europe Monoclonal Antibody Therapeutics market analysis including trends, country-level outlook
(Germany, France, the UK, Spain, Italy, and Other Europe)
Chapter 10 details Asia Pacific Monoclonal Antibody Therapeutics market analysis including trends, country-level outlook
(China, India, Japan, South Korea, South East Asia, and Others are analyzed and forecasted)
Chapter 11 details Latin America Monoclonal Antibody Therapeutics market analysis including trends, country-level outlook
(Brazil, Chile, Argentina, and others included)
Chapter 12 details Middle East and Africa Monoclonal Antibody Therapeutics market analysis including trends, country-level outlook
Chapter 13 presents the competitive analysis of Monoclonal Antibody Therapeutics companies
CHAPTER ONE | EXECUTIVE SUMMARY

The year in review- 2020 at a glance
Monoclonal Antibody Therapeutics Market size outlook, US$ Billion, 2020- 2028
Global healthcare and life sciences market outlook, 2020- 2028

CHAPTER TWO | INTRODUCTION TO MONOCLONAL ANTIBODY THERAPEUTICS MARKET

Market Segments - Types, Applications, and Countries
LIST OF ABBREVIATIONS
Report Guide
Research Methodology

CHAPTER THREE | MACRO-ECONOMIC AND DEMOGRAPHIC OUTLOOK

Healthcare Expenditure of leading 10 Countries, $ Billion, 2010- 2030
GDP Outlook of leading 10 Countries, $ Billion, 2010- 2030
Final Consumption Expenditure of leading 10 Countries, $ Billion, 2010- 2030
Age-wise Population Outlook of leading countries, Millions, 2010- 2030

CHAPTER FOUR | MONOCLONAL ANTIBODY THERAPEUTICS MARKET SIZE ANALYSIS AND OUTLOOK TO 2028

Industry Panorama, 2021
Major Companies and their Strategies
Monoclonal Antibody Therapeutics Market Trends and Insights
Monoclonal Antibody Therapeutics Market Drivers, Challenges, and Opportunities

CHAPTER FIVE | ECONOMIC IMPACT ANALYSIS- MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS

Mild (Rapid recovery) COVID Scenario – Monoclonal Antibody Therapeutics Market Revenue Outlook, US$ Billion, 2020- 2028
Harsh (Reference) COVID Scenario – Monoclonal Antibody Therapeutics Market Revenue Outlook, US$ Billion, 2020- 2028
Severe (Delayed recovery) COVID Scenario – Monoclonal Antibody Therapeutics Market Revenue Outlook, US$ Billion, 2020- 2028

CHAPTER SIX | GLOBAL MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK – SEGMENTATION ANALYSIS

Global Monoclonal Antibody Therapeutics Market Size- Outlook by Product Types, US$ Billion, 2020- 2028
Global Monoclonal Antibody Therapeutics Market Size- Outlook by Application Segments, US$ Billion, 2020- 2028
Global Monoclonal Antibody Therapeutics Market Size- Outlook by End-User Industries, US$ Billion, 2020- 2028
Global Monoclonal Antibody Therapeutics Market Size- Outlook by Regions, US$ Billion, 2020- 2028

CHAPTER SEVEN | NORTH AMERICA MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK – SEGMENTATION ANALYSIS

North America Monoclonal Antibody Therapeutics Market Size Outlook, US$ Billion, 2020- 2028
Trends and Opportunities
North America Monoclonal Antibody Therapeutics Market Size Outlook by Country, US$ Billion, 2020- 2028
United States Monoclonal Antibody Therapeutics Market Size Outlook
Canada Monoclonal Antibody Therapeutics Market Size Outlook
Mexico Monoclonal Antibody Therapeutics Market Size Outlook

CHAPTER EIGHT | EUROPE MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK – SEGMENTATION ANALYSIS

Europe Monoclonal Antibody Therapeutics Market Size Outlook, US$ Billion, 2020- 2028
Trends and Opportunities
Europe Monoclonal Antibody Therapeutics Market Size Outlook by Country, US$ Billion, 2020- 2028
Germany Monoclonal Antibody Therapeutics Market Size Outlook
France Monoclonal Antibody Therapeutics Market Size Outlook
United Kingdom Monoclonal Antibody Therapeutics Market Size Outlook
Spain Monoclonal Antibody Therapeutics Market Size Outlook
Italy Monoclonal Antibody Therapeutics Market Size Outlook
Other Europe Monoclonal Antibody Therapeutics Market Size Outlook

CHAPTER NINE | ASIA PACIFIC MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK – SEGMENTATION ANALYSIS

Asia Pacific Monoclonal Antibody Therapeutics Market Size Outlook, US$ Billion, 2020- 2028
Trends and Opportunities
Asia Pacific Monoclonal Antibody Therapeutics Market Size Outlook by Country, US$ Billion, 2020- 2028
China Monoclonal Antibody Therapeutics Market Size Outlook
India Monoclonal Antibody Therapeutics Market Size Outlook
Japan Monoclonal Antibody Therapeutics Market Size Outlook
South Korea Monoclonal Antibody Therapeutics Market Size Outlook
Southeast Asia Monoclonal Antibody Therapeutics Market Size Outlook
Other Asia/Oceania Monoclonal Antibody Therapeutics Market Size Outlook

CHAPTER TEN | LATIN AMERICA MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK – SEGMENTATION ANALYSIS

Latin America Monoclonal Antibody Therapeutics Market Size Outlook, US$ Billion, 2020- 2028
Trends and Opportunities
Latin America Monoclonal Antibody Therapeutics Market Size Outlook by Country, US$ Billion, 2020- 2028
Brazil Monoclonal Antibody Therapeutics Market Size Outlook
Argentina Monoclonal Antibody Therapeutics Market Size Outlook
Chile Monoclonal Antibody Therapeutics Market Size Outlook
Other Latin America Monoclonal Antibody Therapeutics Market Size Outlook

CHAPTER ELEVEN | MIDDLE EAST AND AFRICA MONOCLONAL ANTIBODY THERAPEUTICS MARKET OUTLOOK – SEGMENTATION ANALYSIS

The Middle East and Africa Monoclonal Antibody Therapeutics Market Size Outlook, US$ Billion, 2020- 2028
Trends and Opportunities
The Middle East and Africa Monoclonal Antibody Therapeutics Market Size Outlook by Country, US$ Billion, 2020- 2028
Saudi Arabia Monoclonal Antibody Therapeutics Market Size Outlook
UAE Monoclonal Antibody Therapeutics Market Size Outlook
South Africa Monoclonal Antibody Therapeutics Market Size Outlook
Other Middle East Monoclonal Antibody Therapeutics Market Size Outlook
Other Africa Monoclonal Antibody Therapeutics Market Size Outlook

CHAPTER TWELVE |COMPETITIVE LANDSCAPE

Leading Companies in Monoclonal Antibody Therapeutics Market
Company fundamentals
Financial situation
Market strategy
SWOT profiles
Appendix A |Data Sources and Research Methodology
Appendix B |Publisher Expertize
Appendix C | Contact Information

LIST OF TABLES

Table 1: Monoclonal Antibody Therapeutics – MARKET SIZE BY TYPE, 2020- 2028
Table 2: GLOBAL Monoclonal Antibody Therapeutics MARKET OUTLOOK, $ BILLION, MILD COVID CASE, 2020- 2028
Table 3: GLOBAL Monoclonal Antibody Therapeutics MARKET OUTLOOK, $ BILLION, HARSH COVID CASE, 2020- 2028
Table 4: GLOBAL Monoclonal Antibody Therapeutics MARKET OUTLOOK, $ BILLION, SEVERE COVID CASE, 2020- 2028
Table 5: Monoclonal Antibody Therapeutics – MARKET SIZE BY APPLICATION, 2020- 2028
Table 6: NORTH AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY APPLICATION, 2020- 2028
Table 7: NORTH AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY TYPE, 2020- 2028
Table 8: NORTH AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY COUNTRY, 2020- 2028
Table 9: EUROPE Monoclonal Antibody Therapeutics MARKET OUTLOOK BY APPLICATION, 2020- 2028
Table 10: EUROPE Monoclonal Antibody Therapeutics MARKET OUTLOOK BY TYPE, 2020- 2028
Table 11: EUROPE Monoclonal Antibody Therapeutics MARKET OUTLOOK BY COUNTRY, 2020- 2028
Table 12: ASIA PACIFIC Monoclonal Antibody Therapeutics MARKET OUTLOOK BY APPLICATION, 2020- 2028
Table 13: ASIA PACIFIC Monoclonal Antibody Therapeutics MARKET OUTLOOK BY TYPE, 2020- 2028
Table 14: ASIA PACIFIC Monoclonal Antibody Therapeutics MARKET OUTLOOK BY COUNTRY, 2020- 2028
Table 15: LATIN AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY APPLICATION, 2020- 2028
Table 16: LATIN AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY TYPE, 2020- 2028
Table 17: LATIN AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY COUNTRY, 2020- 2028
Table 18: MIDDLE EAST AND AFRICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY APPLICATION, 2020- 2028
Table 19: MIDDLE EAST AND AFRICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY TYPE, 2020- 2028
Table 20: MIDDLE EAST AND AFRICA Monoclonal Antibody Therapeutics MARKET OUTLOOK BY COUNTRY, 2020- 2028
Table 21: LEADING Monoclonal Antibody Therapeutics COMPANIES - KEY SNAPSHOT
Table 22: CONSOLIDATED INCOME STATEMENT
Table 23: CONSOLIDATED CASH FLOWS
Table 24: KEY SNAPSHOT
TABLE 25: CONSOLIDATED INCOME STATEMENT
TABLE 26: CONSOLIDATED BALANCE SHEET
TABLE 27: CONSOLIDATED CASH FLOWS
Table 28: KEY SNAPSHOT
TABLE 29: CONSOLIDATED INCOME STATEMENT
TABLE 30: CONSOLIDATED CASH FLOWS
Table 31: KEY SNAPSHOT
TABLE 32: CONSOLIDATED CASH FLOWS
TABLE 33: CONSOLIDATED BALANCE SHEET
TABLE 34: CONSOLIDATED CASH FLOWS

LIST OF FIGURES

FIGURE 1: Monoclonal Antibody Therapeutics - MARKET SNAPSHOT, 2020
Figure 2: GLOBAL HEALTHCARE MARKET OUTLOOK, US$ BILLION, 2020- 2030
FIGURE 3: Monoclonal Antibody Therapeutics- MARKET OUTLOOK, 2020- 2028
FIGURE 4: Monoclonal Antibody Therapeutics – MARKET SEGMENTATION
FIGURE 5: GDP BY COUNTRY OUTLOOK, USD BILLION, CURRENT USD PRICES, 2010- 2030
FIGURE 6: POPULATION OUTLOOK BY COUNTRY, MILLION, 2010- 2030
FIGURE 7: Monoclonal Antibody Therapeutics – MARKET SIZE BY APPLICATION
FIGURE 8: Monoclonal Antibody Therapeutics – MARKET SIZE BY TYPE, USD BILLION, 2020
FIGURE 9: Monoclonal Antibody Therapeutics TYPES: MARKET SIZE FORECAST, USD BILLION, 2020- 2028
FIGURE 10: Monoclonal Antibody Therapeutics TYPES: MARKET SIZE FORECAST, USD BILLION, 2020- 2028
FIGURE 11: Monoclonal Antibody Therapeutics TYPES: MARKET SIZE FORECAST, USD BILLION, 2020- 2028
FIGURE 17: Monoclonal Antibody Therapeutics MARKET SIZE FORECAST, REGION WISE, USD BILLION, 2020
FIGURE 18: Monoclonal Antibody Therapeutics MARKET SIZE FORECAST ACROSS COVID CASES, 2020- 2028
FIGURE 23: NORTH AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 26: THE US DOMINATES THE NORTH AMERICAN Monoclonal Antibody Therapeutics MARKET IN 2021
FIGURE 27: THE US Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 28: CANADA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 29: MEXICO Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 30: EUROPE Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 33: GERMANY DOMINATES THE EUROPEAN Monoclonal Antibody Therapeutics MARKET IN 2021
FIGURE 34: GERMANY Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 35: THE UK Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 36: FRANCE Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 37: SPAIN Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 38: ITALY Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 39: REST OF EUROPE Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 40: ASIA-PACIFIC Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 43: CHINA DOMINATES THE ASIA PACIFIC Monoclonal Antibody Therapeutics MARKET IN
FIGURE 44: CHINA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 45: INDIA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 46: JAPAN Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 47: REST OF ASIA PACIFIC Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 48: LATIN AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 51: BRAZIL DOMINATES THE LATIN AMERICA Monoclonal Antibody Therapeutics MARKET IN 2021
FIGURE 52: BRAZIL Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 53: ARGENTINA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 54: REST OF LATIN AMERICA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 55: MIDDLE EAST AND AFRICA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 59: MIDDLE EAST Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028
FIGURE 60: AFRICA Monoclonal Antibody Therapeutics MARKET OUTLOOK, 2020- 2028


More Publications